Related Experiment Videos

[Calcium channel blockers in the treatment of ischemic heart disease]

J Bultas1

  • 1II. interní klinika, 1. LF UK, Praha.

Vnitrni Lekarstvi
|March 1, 1995
PubMed

Insights

Calcium channel blockers improve heart muscle function by reducing coronary spasms and improving blood flow. New research highlights amlodipine as a superior option due to its pharmacokinetic advantages.

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Review of pathophysiological properties of calcium channel blockers on ischemic heart muscle.
  • Focus on therapeutic effects on coronary spasms and systemic arterial vasodilation.

Purpose:

  • To review the therapeutic effects of calcium channel blockers on the ischemic heart.
  • To highlight the benefits of amlodipine over existing blockers.

Summary:

  • Calcium channel blockers exert beneficial effects on the ischemic heart muscle.
  • They are effective in managing coronary spasms and promoting systemic arterial vasodilation.
  • These agents favorably influence arteriosclerosis, retarding atherogenesis and stabilizing plaques.
  • Amlodipine, a novel calcium channel blocker, demonstrates superior pharmacokinetic properties compared to existing treatments.

Impact:

  • Provides a comprehensive overview of calcium channel blocker mechanisms in ischemic heart disease.
  • Emphasizes the clinical significance of these drugs in managing atherosclerosis.
  • Identifies amlodipine as a promising therapeutic agent with enhanced pharmacokinetic profile.

Related Concept Videos